Case of Application of Syrolimus in a Patient with Progressing Pultifocal Pepatic Nodular Hyperplasia

 

Abstract

Introduction: A case presented to the public demonstrates the possibility of treatment with Sirolimus in a patient with progressive multifocal liver Focal Nodular Hyperplasia (FNH) with progressive growth and a tendency to formation of liver function insufficiency after splenorenal shunt for portal hypertension.

Material and Methods: Patient E. 08.03.2001 year of birth c Diagnosed with multifocal bilobar nodular liver hyperplasia after splenorenal bypass surgery for portal hypertension, established in 2018/ Sirolimus treatment was prescribed from 06.22.18 to the present.

Conclusion: As a result of the treatment with Sirolimus, a normalization of the level of liver enzymes, bilirubin in the blood is noted. According to radiation methods, a reduction in liver size and FNH size is up to 30%.

Read more about this article: https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/case-of-application-of-syrolimus-in-a-patient-with-progressing-pultifocal-pepatic-nodular-hyperplasia.ID.000153.php

Read about Lupine Publishers Google Scholar Articles: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=XbnlB50AAAAJ&cstart=400&pagesize=100&citation_for_view=XbnlB50AAAAJ:9LpHyFPp1DQC

Comments

Post a Comment

Popular posts from this blog

Lupine Publishers-Journal of Clinical Gastroenterology and Hepatology

Image
Portal Hypertensive Gastric Polyps by Umadevi Malladi in Current Trends in Gastroenterologyand Hepatology in Lupine Publishers Portal hypertension is associated with an increased number of gastric polyps, hence the term portal hypertension-associated gastric polyps. Histopathological examination reveals mucosal hyperplasia and vascular proliferation. Formation may be due to mucosal injury that is vascular in nature. Their malignant potential has not been fully elucidated; however, lesions can grow to a large size. Patients with portal hypertension are at increased risk of post polypectomy bleeding and other complications of polypectomy. Surveillance is likely to be safer than multiple polypectomies, therefore in patients with portal hypertension it is essential that gastric polyps are photographed and biopsied during routine surveillance gastroscopies.  https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/portal-hypertensive-gastric-polyps.ID.000...
Read more

Lupine Publishers - Journals of Gastroenterology and Hepatology

Image
The Current Approach to the Hepatocellular Carcinoma; AMini Review of Etiology, Prognosis and Treatment by Nuri Emrah Göret in Current Trends in Gastroenterology and Hepatology - Lupine Publishers   Abstract Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide and is one of the major causes of cancerrelated deaths. HCC is reported to be the second most fatal malignancy. The major risk factors for HCC are well known; the known risk factors include hepatitis C virus (HCV) and hepatitis B virus (HBV). Major advances have been reported in the treatment of HCC. Success of early diagnosis increases when these risk factors are identified, and the cases are followed up. It is reported that in the treatment of early-diagnosed HCC cases, ethanol injection or radiofrequency ablation methods as well as surgical resection should be preferred, particularly in cases without liver cirrhosis and in cases where the tumor is restricted. Similarly, l...
Read more

Lupine Publishers-Gastroenterology open access journal

Image
Fungal Infections in Gastroenterology by Michael AB Naafs MD in Current Trends in Gastroenterology and Hepatology in Lupine Publishers Fungal infections are increasing in gastroenterology. Cirrhotic patients, liver transplantation recipients, and patients with inflammatory bowel disease (IBD) are vulnerable to these infections. The origin of these fungal infections is frequently the GI tract. The advent of sequencing technology can identify now previously unculturable fungi. Dysbiosis of the mycobiome and microbiome can uncheck normal commensal fungi and turn pathogenic by largely unknown mechanisms Resistance to antifungals is becoming a global problem. New antifungals are in development and they are badly needed. In this mini-review the enteric mycobiota and fungal infections in GI disease are discussed https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/fungal-infections-in-gastroenterology.ID.000114.php ht...
Read more